Clinical Trials Logo

Respiration Disorders clinical trials

View clinical trials related to Respiration Disorders.

Filter by:

NCT ID: NCT02272049 Recruiting - Clinical trials for Respiratory Disorders

Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

HPXeMR
Start date: December 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.

NCT ID: NCT02261337 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease and Allied Conditions

Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?

Start date: December 2013
Phase:
Study type: Observational

This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.

NCT ID: NCT02240069 Completed - Clinical trials for Respiratory; Disorder, Functional, Impaired

Wood Smoke Interventions in Native American Populations

EldersAIR
Start date: November 30, 2015
Phase: N/A
Study type: Interventional

A critical need exists for efficient community-based interventions aimed at reduction of environmental exposures relevant to health. Biomass smoke exposures due to residential wood heating are common among rural Native American communities, and such exposures have been associated with respiratory disease in susceptible populations. In many of these communities wood stoves are the most economic and traditionally preferred method of residential heating, but resource scarcity can result in burning of improper wood fuels and corresponding high levels of indoor particulate matter. Community-based participatory research techniques will be used to adapt intervention approaches to meet the cultural context of each participating community. At the community level, investigators will facilitate local development of a tribal agency-led wood bank program ensuring that elderly and/or persons with need have access to dry wood for heating. At the household level, investigators will use a three arm randomized placebo-controlled intervention trial to implement and assess education/outreach on best burn practices (Tx1). The content and delivery strategies of the education intervention will be adapted to each community according to stakeholder input. This educational intervention will be evaluated against an indoor air filtration unit arm (Tx2), as well as a placebo arm (Tx3, sham air filters). Tx3 will be used in comparison with the other two treatment arms to evaluate the penetration and efficacy of the community-level wood bank program. Outcomes will be evaluated with respect to changes in pulmonary function measures and respiratory symptoms and conditions among household elders. The investigators hypothesize that locally-designed education-based interventions at the community and household levels will result in efficacious and sustainable strategies for reducing personal exposures to indoor particulate matter, and lead to respiratory health improvements in elderly Native populations. This study will advance knowledge of cost-effective environmental interventions within two unique Native American communities, and inform sustainable multi-level strategies in similar communities throughout the US to improve respiratory health among at-risk populations.

NCT ID: NCT02229994 Completed - Clinical trials for Cystic Fibrosis of the Adult

Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases

DYSLIM
Start date: March 16, 2010
Phase: N/A
Study type: Observational

The purpose of this study is the psychometric validation of a self-administered dyspnea questionnaire, usable in clinical practice in order to assess dyspnea and its impact on patients with chronic respiratory diseases.

NCT ID: NCT02216357 Completed - Clinical trials for Aspirin Exacerbated Respiratory Disease (AERD)

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Start date: August 2014
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to determine the safety of oral ifetroban compared to placebo as measured by a > 20% decrease in FEV1 compared to baseline following a dose of Investigational Medicinal Product (IMP) (Study Day 1 or 2) prior to initiation of the aspirin challenge.

NCT ID: NCT02102009 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Nutritional Supplementation in Adults With Chronic Respiratory Disease

OFOS
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether nutritional support with a complete formula is effective to improve malnutrition and respiratory function in patients with chronic pulmonary disease compared to the standard hospital dietary advise.

NCT ID: NCT02084043 Completed - Asthma Clinical Trials

In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation

Synchro-Neb
Start date: March 2014
Phase: N/A
Study type: Interventional

Using an adult lung bench model of non invasive ventilation, the aim of the study is to compare an experimental system of breath-synchronized vibrating mesh nebulizer to a conventional vibrating mesh nebulizer during non invasive ventilation in terms of inhaled and lost doses.

NCT ID: NCT02079701 Completed - Pneumonia Clinical Trials

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

Start date: October 2000
Phase: Phase 4
Study type: Interventional

The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: - determining the etiology of clinical pneumonia among U.S. military trainees; - comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and - comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.

NCT ID: NCT02075541 Completed - Clinical trials for Respiratory Disorders

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.

Start date: July 8, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this Phase II study is to assess the safety, reactogenicity and immunogenicity of the investigational Non-typeable Haemophilus influenzae (NTHi) vaccine in patients with moderate and severe persistent airflow obstruction.

NCT ID: NCT02064738 Completed - ASA Triad Clinical Trials

High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)

Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this trial is to test the hypothesis that a treatment diet low in omega-6 fatty acids and high in omega-3 fatty acids can cause improvement in asthma symptoms, nasal symptoms, and pulmonary function in patients with aspirin-exacerbated respiratory disease (AERD).